Global Blood Glucose Monitoring Devices Market Size, Share, Opportunities, And Trends By Type (Continuous Monitoring Devices, Self-Monitoring Devices), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Distribution Channel (Online, Offline), and By Geography - Forecasts From 2025 To 2030

Description

Blood Glucose Monitoring Devices Market Size:

The Global Blood Glucose Monitoring Devices Market is anticipated to rise from USD 15.086 billion in 2025 to USD 22.177 billion in 2030, fueled by an 8.01% CAGR.

Blood Glucose Monitoring Devices Market Trends:

Blood glucose monitoring devices are the devices used to keep track of blood sugar levels in order to better understand diabetes. The increasing need amongst people suffering from diabetes for continuous testing of the blood sugar levels to better analyze how different foods, medications, and activities affect one’s body in terms of diabetes is expected to fuel the market for the devices during the forecast period. The device further helps to track the changes and helps the doctor plan the treatments accordingly for the future.

Given the rapid pace of developments taking place in the healthcare sector across the world, the technological innovations made in these devices help the patient to track the levels even when mobile with the help of portable glucose meters known as glucometers. These devices help the patient as well as their doctors to make conscious plans about the medication dosage, exercise, and diet to be followed. The market witnessed a significant growth rate after the introduction of continuous glucose monitors (CGM) which help track the blood sugar level at very short intervals. This device collects the readings every 5 to 15 minutes giving the patients as well as their healthcare team a better perspective about the medical condition and further help them to make more data-driven decisions.

A key factor expected to be driving the market for blood glucose monitoring devices is the significant shift in the lifestyle pattern which is further fueled by increasing unhealthy habits like smoking and consumption of alcohol and unhealthy food products due to which there has been a substantial rise in the cases of diabetes globally. According to a report by International Diabetes Federation (IDF), about 463 Million in the age group of 20-79 years were living with diabetes in the year 2019 which is expected to rise to 700 million, according to the estimates provided in the report. The rise is majorly witnessed in type 2 diabetes cases globally. The rise in the cases of diabetes is expected to further fuel the growth of the market for Blood glucose monitoring devices in the coming years.

The demand for blood glucose is expected to witness a rapid increase as people and recovered patients become more conscious about their health and are willing to monitor it as much as possible. Furthermore, the demand for the devices increases in hospitals and other healthcare institutions in order to better monitor the health of the recovering patients. The market for the devices is expected to witness a steady growth rate in the coming years owing to the increasing awareness about health.

Blood Glucose Monitoring Devices Market Segmentation Analysis:

The segmentation of the global Blood glucose monitoring devices market has been done into type, end-user, distribution channel, and geography. By type, the classification of the market has been done into Continuous Monitoring Devices, and Self-Monitoring Devices. By end-users, the classification of the market has been done into hospitals, ambulatory surgical centers, and others. By distribution channel, the classification of the market has been done offline and online. Furthermore, on the basis of geography, the global market has been distributed as North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.

Blood Glucose Monitoring Devices Market Competitive Insights:

Prominent/major key market players in the global blood glucose monitoring devices market include Medtronic plc, Abbott Laboratories, BD, and, F. Hoffmann-La Roche Ltd among others. The players in the global blood glucose monitoring devices market are implementing various growth strategies to gain a competitive advantage over their competitors in this market.

Major market players in the market have been covered along with their relative competitive strategies and the report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the global blood glucose monitoring devices market.

The Blood Glucose Monitoring Devices Market is analyzed into the following segments:

• By Type

  • Continuous Monitoring Devices

  • Self-Monitoring Devices

  • Flash Glucose Monitoring (FGM) Systems

• By End-User

  • Hospitals

  • Home Care Settings

  • Clinics/Diagnostic Centers

  • Ambulatory Surgical Centers

  • Long-Term Care Facilities

  • Others

• By Distribution Channel

  • Online

  • Offline

• By Geography

  • North America

    • USA

    • Canada

    • Mexico

  • South America

    • Brazil

    • Argentina

    • Others

  • Europe

    • Germany

    • France

    • United Kingdom

    • Spain

    • Others

  • Middle East and Africa

    • Saudi Arabia

    • UAE

    • Others

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Indonesia

    • Thailand

    • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY TYPE

5.1. Introduction

5.2. Continuous Monitoring Devices

5.3. Self-Monitoring Devices

5.4. Flash Glucose Monitoring (FGM) Systems

6. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY END-USER

6.1. Introduction

6.2. Hospitals

6.3. Home Care Settings

6.4. Clinics/Diagnostic Centers

6.5. Ambulatory Surgical Centers

6.6. Long-Term Care Facilities

6.7. Others

7. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction

7.2. Online

7.3. Offline

8. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Abbott Laboratories

10.2. Medtronic plc

10.3. BD

10.4. F. Hoffmann-La Roche Ltd.

10.5. DexCom, Inc.

10.6. Ascensia Diabetes Care Holdings AG

10.7. Sanofi S.A.

10.8. B. Braun Melsungen AG

10.9. LifeScan, Inc.

10.10. Terumo Medical Corporation

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Abbott Laboratories

Medtronic plc

BD

F. Hoffmann-La Roche Ltd.

DexCom, Inc.

Ascensia Diabetes Care Holdings AG

Sanofi S.A.

B. Braun Melsungen AG

LifeScan, Inc.

Terumo Medical Corporation

Related Reports